Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5433-01-2 | MDL No. : | MFCD01318112 |
Formula : | C9H11Br | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GBSGGFCCQZUXNB-UHFFFAOYSA-N |
M.W : | 199.09 | Pubchem ID : | 138499 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 48.72 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.55 cm/s |
Log Po/w (iLOGP) : | 2.66 |
Log Po/w (XLOGP3) : | 4.17 |
Log Po/w (WLOGP) : | 3.57 |
Log Po/w (MLOGP) : | 3.98 |
Log Po/w (SILICOS-IT) : | 3.47 |
Consensus Log Po/w : | 3.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.08 |
Solubility : | 0.0166 mg/ml ; 0.0000833 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.88 |
Solubility : | 0.0263 mg/ml ; 0.000132 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.08 |
Solubility : | 0.0167 mg/ml ; 0.0000838 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 1.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | Stage #1: With sulfuric acid; sodium nitrite In ethanol; water at -5℃; Inert atmosphere Stage #2: With copper In ethanol; water for 4 h; Reflux; Inert atmosphere |
2-Bromo-4-isopropylaniline 12 (2.65 g, 12.4 mmol, 1.0 eq.) was added over 15 min. to a mixture of ethanol 96percent (23 mL) and conc. sulfuric acid (2.5 mL) at -5°C under vigorous stirring. Then, a solution of sodium nitrite (1.42 g, 20.7 mmol, 1.67 eq.) in water (3 mL) was added at -5°C over 1 h and the resulting mixture was stirred for 30 minutes, followed by addition of copper powder (12.0 g). The reaction mixture was refluxed for 4 h and filtered through glass frit. The filtrated was poured into cold water (60 mL) and the organic product was extracted with DCM (4 x 50 mL). The combined organic extracts were dried over potassium carbonate and concentrated. Fractional distillation (11 mmHg, 89-90°C) of the residue gave 13 as yellowish oil (1.91g, 77percent yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | Stage #1: With magnesium In tetrahydrofuran at 50 - 60℃; Stage #2: for 0.666667 h; Stage #3: With hydrogenchloride In tetrahydrofuran; water |
Intermediate C. Method A: 3-Isopropylbenzoic acid (C-a). To a solution of l-bromo-3-isopropylbenzene (1.24 g, 6.23 mmol) in THF (18 ml) was added magnesium wire (0.151 g, 1 eq.). The mixture was heated to 50 to 600C until the magnesium was dissolved. To this solution was added an excess of solid CO2 and after 40 min the reaction mixture was acidified with IM aq. HCl. The product was extracted into DCM, the organic layer was dried over MgSO4 and evaporated, yielding the target product (1.07 g <n="127"/>(quantitative)). 1H-NMR (CDCl3) δ (ppm) 8.00 (s, IH), 7.95 (d, IH), 7.49 (d, IH), 7.41 (t, IH), 3.00 (m, IH), 1.30 (d, 6H). |
92% | Stage #1: With tert.-butyl lithium In diethyl ether; pentane at -78℃; for 0.166667 h; Stage #3: With hydrogenchloride In diethyl ether; water; pentane |
Method 72; 3-Isopropylbenzoic acid; A solution of l-bromo-3-isopropylbenzene (500 mg, 2.51 mmol) in pentane/ether (1:1; 8 ml) was treated with t-butyllithium (1.7 M in pentane, 3.0 ml) at -78 °C. The mixture was stirred at -78 0C for 10 min and then CO2 (g) was bubbled into the mixture for several minutes. The reaction was quenched with 10percent HCl and extracted with EtOAc. The organic layer was dried with NaCl (sat) then Na2SO4 (s). The solvents were removed under reduced pressure to give a white solid (379 mg, 92percent); m/z 166. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | Stage #1: With n-butyllithium In tetrahydrofuran at -60℃; for 0.5 h; Inert atmosphere Stage #2: at -30℃; for 3 h; Inert atmosphere |
Into a 500-mL round-bottom flask purged and maintained with an inert atmosphere of N2 was placed a solution of 1-bromo-3- (propan-2-yl)benzene (5.0 g, 25.11 mmol, 1.00 equiv) in THF (250 mL). This was followed by the addition of n-BuLi (20 mL, 2.00 equiv) dropwise with stirring at -60 °C. The mixture was stirred at -60°C for 30 mm. To this was added N-methoxy-N-methylacetamide (3.9 g, 37.82 mmol, 1.50 equiv) dropwise with stirring at -30 °C. The resulting solution was stirred for 3 h at -30 °C in a liquid N2 bath. The reaction was then quenched by the addition of 20 mL of water. The resulting solution was diluted with 200 mL of EtOAc, washed with 2x100 mL of brine, dried over anhydrous Na2SO4 and concentrated under vacuum. The residue was applied onto a silica gel column with EtOAc/petroleum ether (1:10). This resulted in 2.7 g (66percent) of the title product as colorless oil. |
[ 22385-77-9 ]
1-Bromo-3,5-di-tert-butylbenzene
Similarity: 0.94
[ 22385-77-9 ]
1-Bromo-3,5-di-tert-butylbenzene
Similarity: 0.94